Ex vivo RSA and Pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017.

التفاصيل البيبلوغرافية
العنوان: Ex vivo RSA and Pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017.
المؤلفون: Yade MS; Centre International de Recherche et de Formation en Génomique Appliquée, et de Surveillance Sanitaire (CIGASS), Cheikh Anta Diop University of Dakar., Dièye B; Centre International de Recherche et de Formation en Génomique Appliquée, et de Surveillance Sanitaire (CIGASS), Cheikh Anta Diop University of Dakar., Coppée R; Université Paris Cité and Sorbone Paris Nord, Inserm, IAME., Mbaye A; Centre for Research and Training in Infectiology of Guinea (CRTIG)., Diallo MA; Centre International de Recherche et de Formation en Génomique Appliquée, et de Surveillance Sanitaire (CIGASS), Cheikh Anta Diop University of Dakar., Diongue K; Cheikh Anta Diop University of Dakar., Bailly J; University of Paris Cité, IRD, MERIT., Mama A; Université de Paris, Institut Cochin, Inserm U1016., Fall A; Centre International de Recherche et de Formation en Génomique Appliquée, et de Surveillance Sanitaire (CIGASS), Cheikh Anta Diop University of Dakar., Thiaw AB; Department of Biochemistry and Functional Genomics, Faculty of Medicine and Health Sciences., Ndiaye IM; Centre International de Recherche et de Formation en Génomique Appliquée, et de Surveillance Sanitaire (CIGASS), Cheikh Anta Diop University of Dakar., Ndiaye T; Centre International de Recherche et de Formation en Génomique Appliquée, et de Surveillance Sanitaire (CIGASS), Cheikh Anta Diop University of Dakar., Gaye A; Centre International de Recherche et de Formation en Génomique Appliquée, et de Surveillance Sanitaire (CIGASS), Cheikh Anta Diop University of Dakar., Tine A; Centre International de Recherche et de Formation en Génomique Appliquée, et de Surveillance Sanitaire (CIGASS), Cheikh Anta Diop University of Dakar., Diédhiou Y; Centre International de Recherche et de Formation en Génomique Appliquée, et de Surveillance Sanitaire (CIGASS), Cheikh Anta Diop University of Dakar., Mbaye AM; Centre International de Recherche et de Formation en Génomique Appliquée, et de Surveillance Sanitaire (CIGASS), Cheikh Anta Diop University of Dakar., Doderer-Lang C; Université de Strasbourg, UR7292 Dynamics of Host-Pathogen Interactions., Garba MN; Centre International de Recherche et de Formation en Génomique Appliquée, et de Surveillance Sanitaire (CIGASS), Cheikh Anta Diop University of Dakar., Bei AK; Yale School of Public Health., Ménard D; Université de Strasbourg, UR7292 Dynamics of Host-Pathogen Interactions., Ndiaye D; Centre International de Recherche et de Formation en Génomique Appliquée, et de Surveillance Sanitaire (CIGASS), Cheikh Anta Diop University of Dakar.
المصدر: Research square [Res Sq] 2023 Feb 06. Date of Electronic Publication: 2023 Feb 06.
نوع المنشور: Preprint
اللغة: English
بيانات الدورية: Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE
مستخلص: Introduction: Malaria control is highly dependent on the effectiveness of artemisinin-based combination therapies (ACTs), the current frontline malaria curative treatments. Unfortunately, the emergence and spread of parasites resistant to artemisinin (ART) derivatives in Southeast Asia and South America, and more recently in Rwanda and Uganda (East Africa), compromise their long-term use in Sub-Saharan Africa where most malaria deaths occur.
Methods: Here, we evaluated ex vivo susceptibility to dihydroartemisinin (DHA) from 38 P. falciparum isolates collected in 2017 in Thiès (Senegal) expressed with the Ring-stage Survival Assay (RSA). We explored major and minor variants in the full Pfkelch13 gene, the main determinant of ART resistance using a targeted-amplicon deep sequencing (TADS) approach.
Results: All samples tested in the ex vivo RSA were found to be susceptible to DHA. Both non-synonymous mutations K189T and K248R were observed each in one isolate, as major (99%) or minor (5%) variants, respectively.
Conclusion: Altogether, investigations combining ex vivo RSA and TADS are a useful approach for monitoring ART resistance in Africa.
التعليقات: Update in: Malar J. 2023 May 26;22(1):167. doi: 10.1186/s12936-023-04588-1. (PMID: 37237307)
References: Genome Med. 2017 Jan 24;9(1):5. (PMID: 28118860)
Nat Med. 2020 Oct;26(10):1602-1608. (PMID: 32747827)
Lancet Infect Dis. 2021 Apr;21(4):e82-e92. (PMID: 33125913)
N Engl J Med. 2018 Nov 15;379(20):1962-1964. (PMID: 30428283)
Antimicrob Agents Chemother. 2015 Aug;59(8):5061-4. (PMID: 26033725)
Sci Rep. 2020 Jun 1;10(1):8907. (PMID: 32483161)
N Engl J Med. 2009 Jul 30;361(5):455-67. (PMID: 19641202)
Sci Rep. 2019 Jul 23;9(1):10675. (PMID: 31337835)
Antimicrob Agents Chemother. 2015 Oct 26;60(1):624-7. (PMID: 26503652)
Clin Infect Dis. 2022 Sep 30;75(7):1242-1244. (PMID: 35213688)
Antimicrob Agents Chemother. 2015 Jan;59(1):326-30. (PMID: 25348538)
Lancet Infect Dis. 2021 Aug;21(8):1120-1128. (PMID: 33864801)
BMC Infect Dis. 2020 Jul 22;20(1):533. (PMID: 32698879)
Antimicrob Agents Chemother. 2019 Oct 22;63(11):. (PMID: 31427297)
J Infect Dis. 2022 Apr 19;225(8):1411-1414. (PMID: 34216470)
J Infect Dis. 2021 Mar 29;223(6):985-994. (PMID: 33146722)
Malar J. 2020 May 24;19(1):191. (PMID: 32448203)
Nature. 2014 Jan 2;505(7481):50-5. (PMID: 24352242)
Emerg Infect Dis. 2021 Jan;27(1):294-296. (PMID: 33350925)
Lancet Infect Dis. 2018 Mar;18(3):337-345. (PMID: 29398391)
Emerg Infect Dis. 2018 Apr;24(4):718-726. (PMID: 29553316)
Malar J. 2021 Jun 22;20(1):275. (PMID: 34158055)
Malar J. 2020 Mar 30;19(1):134. (PMID: 32228566)
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0132021. (PMID: 34606334)
Antimicrob Agents Chemother. 2017 Feb 23;61(3):. (PMID: 28069653)
PLoS One. 2021 Mar 26;16(3):e0249357. (PMID: 33770151)
Lancet Infect Dis. 2013 Dec;13(12):1043-9. (PMID: 24035558)
Malar J. 2016 Nov 26;15(1):572. (PMID: 27887614)
Malar J. 2014 Dec 04;13:472. (PMID: 25471113)
N Engl J Med. 2021 Sep 23;385(13):1163-1171. (PMID: 34551228)
معلومات مُعتمدة: U19 AI089696 United States AI NIAID NIH HHS
تواريخ الأحداث: Date Created: 20230217 Latest Revision: 20240626
رمز التحديث: 20240626
مُعرف محوري في PubMed: PMC9934778
DOI: 10.21203/rs.3.rs-2538775/v1
PMID: 36798264
قاعدة البيانات: MEDLINE
الوصف
DOI:10.21203/rs.3.rs-2538775/v1